Clinical trials
COVID clinical trials
Below are recruiting covid clinical trials, each written for real people, not researchers. We’re tracking 337 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05774093Recruiting
Study how COVID immunity affects reinfection risk
This study looks at how well COVID-19 protection (immune barrier) holds up over time and how likely people are to get reinfected. It may help researchers understand who is more at risk after prior infection and why.
Guangzhou, GuangdongAges Any age - NCT05946512Recruiting
Yoga breathing plus lung MRI measurements for post-COVID symptoms
This study uses breathing exercises from yoga and MRI (a scan of the body) measurements to see how well yoga breathing can improve ongoing breathing symptoms after COVID-19. It also compares results in a few other specific groups and healthy volunteers.
Innsbruck, TyrolAges 18–50 - NCT06012552RecruitingPhase 2
Tianeptine for COVID-19 brain fog
This study tests whether the medication tianeptine can improve brain fog and thinking problems that persist after COVID-19. It may help if you are 18 or older, have had COVID-19, and have noticed new memory or concentration issues.
WarsawAges 18 years+ - NCT05582512Recruiting
Study of long-term effects in children after COVID-19
This study looks at what long-term health effects children may have after getting COVID-19, and how those effects change over time. You may be asked to share health information and possibly complete a scan that can’t be done if certain metal is present.
Taipei, Chung Cheng DistrictAges Up to 18 years - NCT05191381Recruiting
Immune treatment using exosome therapy for severe COVID-19
This trial tests whether immune-supporting treatment made from exosomes can help people with critically severe COVID-19 and lung damage. If you qualify, you may receive this therapy as part of the study to see if it improves outcomes.
UlmAges 18–90 - NCT05638724Recruiting
Long COVID health registry for people of all ages
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
Munich, BavariaAges Any age - NCT05805566Recruiting
Study of care for long COVID symptoms in adults
This study follows people who enter a specialized care pathway for long COVID (post-COVID syndrome) to better understand symptoms, needs, and outcomes. It may help improve how multidisciplinary care is organized for long COVID over time.
Pierre-BéniteAges 18 years+ - NCT04706390Recruiting
Study compares immune response after COVID infection vs vaccination
This study looks at how your immune system responds after natural COVID-19 infection compared with after COVID vaccination. It may help researchers understand how well different experiences train the body’s defenses.
BergenAges 20–100 - NCT07798648RecruitingPhase 3
COVID-19 vaccine study for children and adults
This study tests a COVID-19 vaccine in children and adults. It may help protect against COVID-19.
Homestead, FloridaAges 5 years+ - NCT05562505Recruiting
Using ECMO to help you breathe, sit up, and come off a ventilator
This trial tests whether a heart-lung machine called venovenous ECMO can help people with severe breathing failure get less sedated, get extubated (have the breathing tube removed), and start moving. It’s for certain adults who are on a ventilator for a short time and have specific oxygenation problems.
Darlinghurst, New South WalesAges 18–65 - NCT07781501Recruiting
Study of long-term effects of covid-19
This study looks at the long-term effects of COVID-19, sometimes called Long COVID. By studying saliva and health info, researchers hope to understand why some people have lasting symptoms.
Chapel Hill, North CarolinaAges 18–75 - NCT07770022Recruiting
Long COVID biomarker study for UCSF participants
This study looks for signs of Long COVID in the blood and gut to better understand the condition. If you have Long COVID or were exposed to the virus without developing it, you may be able to help.
San Francisco, CaliforniaAges 18 years+ - NCT05463380Recruiting
Study of hospitalized adults with COVID-19
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
DüsseldorfAges 18 years+ - NCT07746544RecruitingPhase 3
Secutrelvir for treating covid-19 in adolescents and adults
This study tests an experimental oral antiviral, secutrelvir, for people with mild to moderate COVID-19 who are not sick enough to need hospital care. The medicine aims to reduce symptoms and help you recover faster.
Multiple LocationsAges 12–74 - NCT07730450RecruitingPhase 4
COVID-19 vaccine study for healthy adults aged 18 to 64
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Walnut Creek, CaliforniaAges 18–64 - NCT07726082Recruiting
A group program to help with long-term fatigue
This study tests a new way to help people with long-term fatigue that gets in the way of daily life. It uses a group program that focuses on making small, helpful choices to feel better.
BaselAges 18–65 - NCT06311435Recruiting
Blood test for long COVID diagnosis
This study is testing a new blood test that looks for specific RNA markers to help diagnose long COVID. If you have new, lasting symptoms after a confirmed COVID-19 infection, this study may help find answers.
Iowa City, IowaAges 18 years+ - NCT07661862Recruiting
Managing heart and lung symptoms after COVID-19
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
Hobart, TasmaniaAges 40 years+ - NCT06355258RecruitingPhase 1
Troxerutin to prevent blood clots in COVID-19 patients
This trial tests if the drug troxerutin can prevent dangerous blood clots in adults hospitalized with mild or severe COVID-19. If you have COVID-19 and are not already on blood thinners or at high risk for bleeding, you may be able to join.
Shaoxing, ZhejiangAges 18 years+ - NCT06633666Recruiting
Acupuncture for Long COVID brain and mood symptoms
This study tests whether acupuncture can help with brain fog, memory problems, depression, or anxiety that started after COVID-19 and won't go away. If you have Long COVID and these symptoms, acupuncture might offer relief.
Kowloon Tong, KowloonAges 18–80 - NCT07627815RecruitingPhase 2
Safety and Efficacy of PNMR for Long COVID
This study tests whether PNMR (a supplement product) can safely reduce symptoms of long COVID—the lingering fatigue, brain fog, and other problems that some people experience months after COVID infection. You'll take the study product, follow diet and exercise guidelines, and complete questionnaires and a walking test.
Brampton, OntarioAges 19 years+ - NCT05268523Recruiting
Online self-management program for long COVID symptoms
This trial tests an online self-management program to help people cope with long COVID symptoms in everyday life. It may help if you’re struggling with ongoing symptoms like mood changes, memory/thinking issues, or physical problems after COVID.
Toronto, OntarioAges 18 years+ - NCT05308537Recruiting
Mindful compassion program for nurses feeling emotionally exhausted
This study tests whether a mindful compassion training program can reduce psychological distress in nurses who feel emotionally drained. It targets nurses working on COVID-19 hospital units and compares the program to a wait-and-see group.
Verona, ItaliaAges 25–65 - NCT06248151Recruiting
Exercise and heart health after COVID-19
This study looks at how a single exercise session affects the heart and blood vessels in people with lasting COVID-19 symptoms. It may help understand if exercise is safe and helpful for recovery.
São PauloAges 18 years+
Hear when a new COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid?
- Yes. Clin2 currently lists 337 recruiting covid studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.